Skip to content

Effects of Baduanjin Exercise on Heart Failure Patients

Effects of Baduanjin Exercise on Heart Failure Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04981197
Enrollment
80
Registered
2021-07-28
Start date
2013-12-17
Completion date
2014-11-30
Last updated
2022-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

heart failure, Baduanjin exercise, fatigue, sleep quality, psychological distress, quality of life

Brief summary

This study was a parallel, randomized controlled trial with a longitudinal research design. Participants were randomly assigned to either the Baduanjin exercise group or the control group. The Baduanjin exercise group received a 12-week Baduanjin exercise programme. The control group received usual care. Fatigue, sleep quality, psychological distress, quality of life were assessed by a structured questionnaire at baseline, 4 weeks, 8 weeks, and 12 weeks after enrollment.

Detailed description

This study was a parallel, randomized controlled trial with a longitudinal research design. Participants were randomly assigned to either the Baduanjin exercise group or the control group. Patients in the intervention group underwent a 12-week Baduanjin exercise programme consisting of 12 weeks of Baduanjin exercise, a 35-min Baduanjin exercise demonstration video, a picture-based educational brochure, and a performance record form. The control group received usual care. Fatigue, sleep quality, psychological distress, quality of life were assessed by a structured questionnaire at baseline, 4 weeks, 8 weeks, and 12 weeks after enrollment.

Interventions

Patients in the intervention group underwent a 12-week Baduanjin exercise programme consisting of 12 weeks of Baduanjin exercise, a 35-min Baduanjin exercise demonstration video, a picture-based educational brochure, and a performance record form.

Sponsors

Ministry of Science and Technology, Taiwan
CollaboratorOTHER_GOV
National Yang Ming Chiao Tung University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with stable heart failure by a physician according to the New York Heart Association (NYHA) class I and II * Aged 20 years or older * Able to communicate and speak Chinese * Have video devices available to use at home

Exclusion criteria

* Impaired mobility, defined as a limitation in independent, purposeful physical movement of the body or of one or more extremities * Unstable angina or myocardial infarction, unstable serious arrhythmia, unstable structural valvular disease, open-heart surgery, or chronic obstructive pulmonary disease (COPD) * Diagnosis of major depression and cognitive disorders * Unstable vital signs (defined as blood pressure \> 180/110 mmHg or \< 90/60 mmHg and resting heart rate \> 100 beats/min).

Design outcomes

Primary

MeasureTime frameDescription
Changes in the modified Piper Fatigue Scale scoresbaseline, 4 week, 8 week, 12 weekChanges from baseline modified Piper Fatigue scale at 4 weeks, 8 weeks, 12 weeks.The shortened modified Piper Fatigue scale is composed of 15 items that measure two domains of fatigue: severity and temporality. Each item is scored from 0 to 3, with a total possible score of 0-45. Higher scores indicate greater fatigue.
Changes in the Minnesota Living with Heart Failure Questionnaire scoresbaseline, 4 week, 8 week, 12 weekChanges from baseline Minnesota Living with Heart Failure Questionnaire at 4 weeks, 8 weeks, 12 weeks.The Minnesota Living with Heart Failure Questionnaire is composed of 21 items. Each item score ranges from 0 to 5. The total possible score ranges from 0 to 105, with higher scores indicating a lower quality of life.

Secondary

MeasureTime frameDescription
Changes in the Pittsburgh Sleep Quality Index scoresbaseline, 4 week, 8 week, 12 weekChanges from baseline Pittsburgh Sleep Quality Index at 4 weeks, 8 weeks, 12 weeks.The Pittsburgh Sleep Quality Index is composed of 21 items, 7 dimensions. Each dimension is scored from 0 to 3, with a total possible score of 0-21. Higher scores indicate poor sleep.
Changes in the Hospital Anxiety and Depression Scale scoresbaseline, 4 week, 8 week, 12 weekChanges from baseline Hospital Anxiety and Depression Scale at 4 weeks, 8 weeks, 12 weeks.The Hospital Anxiety and Depression Scale is composed of 14 items, 2 subscales. Each item is scored from 0 to 3, with a total possible score of 0-21 for each subscale. Higher scores indicate higher anxiety and depression
Changes in heart rate variabilitybaseline, 4 week, 8 week, 12 weekChanges from baseline heart rate variability at 4 weeks, 8 weeks, 12 weeks.The heart rate variability was measured using the Heart Rate Master ANSWatch® Wrist Physiological Monitor TS-0411Deluxe Advanced (made in Taiwan)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026